4 Stocks Make It On Today's Healthcare & Biotech Stock Watchlist
Powered by HealthTechMovers.com
We added 4 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Halozyme Therapeutics, Inc., HALO
Summary: Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company also licenses its novel drug delivery technology, ENHANZE. Several companies including Roche, Takeda, J&J, AbbVie, Lilly, Bristol-Myers and others are using this technology for developing subcutaneous formulation of their currently marketed drugs. It also recognizes revenues from sale of drug products to its collaboration partners for development of drugs using its ENHANZE platform. The company also has one approved product in its portfolio, Hylenex recombinant as an adjuvant to facilitate subcutaneous fluid administration. Although Halozyme has one marketed product, it derives the majority of its revenues from royalties on sales of partnered drugs.
- Last Price: $38.10
- Price Change: $-0.67, -1.73%
- Yearly Gain: 16.76%
- Market Cap: $4.84B
- P/E Ratio: 18.14
Here are 3rd party ratings for HALO:
- TipRanks.com: Buy
- TradingView.com:
- Yahoo! Finance: Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Top 31% (79 out of 251)
What is the sentiment on the street regarding Halozyme Therapeutics, Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bearish
- Blogger Consensus:
- Media Buzz: Strong Buy
- Insider Signal: Selling
- Investor Sentiment: Positive
- Hedge Fund signal: Low Risk
If you are interested in HALO or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on HALO before you decide to make any investment.
Click here for chart >>
Biohaven Pharmaceutical Holding Company Ltd., BHVN
Summary: Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
- Last Price: $38.80
- Price Change: $-1.03, -2.59%
- Yearly Gain: 185.71%
- Market Cap: $3.17B
- P/E Ratio: -6.77
Here are 3rd party ratings for BHVN:
- TipRanks.com: Buy
- TradingView.com:
- Yahoo! Finance: Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 31% (79 out of 251)
What is the sentiment on the street regarding Biohaven Pharmaceutical Holding Company Ltd. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bearish
- Blogger Consensus:
- Media Buzz: Sell
- Insider Signal: Selling
- Investor Sentiment: Positive
- Hedge Fund signal: Medium Risk
If you are interested in BHVN or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on BHVN before you decide to make any investment.
Click here for chart >>
Schrödinger, Inc., SDGR
Summary: Schr'dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr'dinger Inc. is based in NEW YORK.
- Last Price: $24.38
- Price Change: $-0.06, -0.25%
- Yearly Gain: -21.05%
- Market Cap: $1.77B
- P/E Ratio: 45.15
Here are 3rd party ratings for SDGR:
- TipRanks.com: Buy
- TradingView.com:
- Yahoo! Finance: Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 38% (95 out of 251)
What is the sentiment on the street regarding Schrödinger, Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bullish
- Blogger Consensus:
- Media Buzz: Sell
- Insider Signal: Buying
- Investor Sentiment: Negative
- Hedge Fund signal: Medium Risk
If you are interested in SDGR or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on SDGR before you decide to make any investment.
Click here for chart >>
Jasper Therapeutics, Inc., JSPR
Summary: Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif.
- Last Price: $23.87
- Price Change: $1.95, 8.90%
- Yearly Gain: 82.21%
- Market Cap: $360.09M
- P/E Ratio: -0.39
Here are 3rd party ratings for JSPR:
- TipRanks.com: Buy
- TradingView.com:
- Yahoo! Finance: Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 31% (79 out of 251)
What is the sentiment on the street regarding Jasper Therapeutics, Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bullish
- Blogger Consensus:
- Media Buzz: Sell
- Insider Signal: Buying
- Investor Sentiment: Positive
- Hedge Fund signal: Medium Risk
If you are interested in JSPR or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on JSPR before you decide to make any investment.
Click here for chart >>
Thanks for reading!